Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G et al (2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in idiopathic intracranial hypertension
These belong to a class of medicines called GLP-1 receptor agonists, which lower blood sugar, suppress appetite and prolong satiety by mimicking gut hormones
Our study introduces Sema, highlighting its capacity to correct abnormal NR4a1 expression mediated by Creb5 in the TAC model, thus ameliorating metabolic dysregulation associated with myocardial remodeling
Additionally, rapid weight loss itself is associated with adaptive thermogenesis , a physiological response where the body conserves energy by reducing heat production
Genetic insights into how your body processes minerals and manages GLP-1 sensitivity can help your care team recommend whether magnesium glycinate fits your specific wellness plan during tirzepatide therapy